BlackRock’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154M | Buy |
3,792,185
+638,457
| +20% | +$25.9M | ﹤0.01% | 1762 |
|
|
2025
Q1 | $162M | Sell |
3,153,728
-385,117
| -11% | -$19.8M | ﹤0.01% | 1704 |
|
|
2024
Q4 | $196M | Sell |
3,538,845
-216,659
| -6% | -$12M | ﹤0.01% | 1668 |
|
|
2024
Q3 | $124M | Buy |
3,755,504
+488,790
| +15% | +$16.1M | ﹤0.01% | 1943 |
|
|
2024
Q2 | $88.8M | Buy |
3,266,714
+614,034
| +23% | +$16.7M | ﹤0.01% | 2078 |
|
|
2024
Q1 | $96.4M | Buy |
2,652,680
+136,541
| +5% | +$4.96M | ﹤0.01% | 2036 |
|
|
2023
Q4 | $51M | Buy |
2,516,139
+305,816
| +14% | +$6.19M | ﹤0.01% | 2412 |
|
|
2023
Q3 | $39.3M | Buy |
2,210,323
+10,570
| +0.5% | +$188K | ﹤0.01% | 2507 |
|
|
2023
Q2 | $39.7M | Buy |
2,199,753
+742,493
| +51% | +$13.4M | ﹤0.01% | 2582 |
|
|
2023
Q1 | $18.3M | Buy |
1,457,260
+116,001
| +9% | +$1.46M | ﹤0.01% | 2964 |
|
|
2022
Q4 | $19.7M | Buy |
1,341,259
+222,498
| +20% | +$3.26M | ﹤0.01% | 2992 |
|
|
2022
Q3 | $19.2M | Buy |
1,118,761
+103,128
| +10% | +$1.77M | ﹤0.01% | 3006 |
|
|
2022
Q2 | $14.8M | Buy |
1,015,633
+575,675
| +131% | +$8.41M | ﹤0.01% | 3193 |
|
|
2022
Q1 | $7.4M | Sell |
439,958
-9,000
| -2% | -$151K | ﹤0.01% | 3663 |
|
|
2021
Q4 | $10.1M | Buy |
448,958
+7,338
| +2% | +$165K | ﹤0.01% | 3602 |
|
|
2021
Q3 | $9.52M | Buy |
441,620
+3,264
| +0.7% | +$70.4K | ﹤0.01% | 3640 |
|
|
2021
Q2 | $12.7M | Buy |
438,356
+98,559
| +29% | +$2.86M | ﹤0.01% | 3496 |
|
|
2021
Q1 | $11M | Buy |
339,797
+17,374
| +5% | +$560K | ﹤0.01% | 3455 |
|
|
2020
Q4 | $13.3M | Buy |
+322,423
| New | +$13.3M | ﹤0.01% | 3156 |
|